Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia

Abstract Introduction The advent of new disease-modifying therapies (DMTs), such as monoclonal antibodies (mAbs), resulted in significant changes in the treatment guidelines for Multiple sclerosis (MS) and improvement in the clinical outcomes. However, mAbs, such as rituximab, natalizumab, and ocrel...

Full description

Saved in:
Bibliographic Details
Main Authors: Mansour A. Alharbi (Author), Fahad Aldosari (Author), Ahmed Hasan Althobaiti (Author), Faris M. Abdullah (Author), Salman Aljarallah (Author), Nuha M. Alkhawajah (Author), Miteb Alanazi (Author), Yazed AlRuthia (Author)
Format: Book
Published: BMC, 2023-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available